A 14-year-old with progressive pain and swelling over the left knee

Last updated: April 7, 2026Bookmark

A 14-year-old boy presents with a 3-month history of progressive pain and swelling around his left knee. The pain is dull, constant, and often wakes him at night. His parents report that he has developed a limp and is unable to participate in sports. He has also experienced some weight loss and fatigue, though there has been no history of fever or night sweats.

Q1. What warning signs suggest that this child might have a bone tumour?

Unremitting bone or joint pain (especially pain that wakes the patient from sleep)

Rapid progression of bone or joint pain/swelling

Constitutional symptoms such as weight loss

Q2. What is the differential diagnosis for a bone tumour in children?

Osteogenic sarcoma

Ewing’s sarcoma

Osteogenic sarcoma is the most common primary bone tumour in individuals < 30 years. It is seen in older children and young adults aged 10 – 25 years (75%), with a second peak in older adults aged 60 – 79 years (secondary to radiation or Paget’s disease)

Q3. What are the most common bone tumours by age group?

Most common bone tumors by age group

Age groupCommon tumors
PaediatricEwing sarcoma, osteogenic sarcoma (osteosarcoma)
AdultMetastasis to bone, multiple myeloma, lymphoma, sarcoma of soft tissue

Q4. List the most common bone tumours by location?

Bone tumours by location

LocationTumors
SkullEosinophilic granuloma, metastasis, myeloma
MandibleAdamantinoma, dentogenic cyst
HumerusAll tumors, simple bone cysts
RibsMetastases, enchondroma, chondrosarcoma, Ewing’s sarcoma
SpineMetastases, myeloma, osteoblastoma, chordoma, hemangioma, aneurysmal bone cyst
PelvisOsteosarcoma, chondrosarcoma, simple bone cyst, lymphoma, Ewing’s sarcoma, AND chordoma
Distal radiusGiant cell tumor, eosinophilic granuloma
HandsEnchondroma
Proximal femurSimple bone cyst, fibrous dysplasia, enchondroma, Ewing sarcoma, eosinophilic granuloma
Around the kneeAll tumors, osteosarcoma, Ewing’s sarcoma
Tibia shaftNon-ossifying fibroma, fibrous dysplasia, adamantinoma, osteoid osteoma
CalcaneusSimple bone cyst, Ewing’s sarcoma, osteoblastoma, chondroblastoma

On physical examination, there is a firm, tender swelling over the distal femur measuring approximately 6 cm. The swelling is immobile and associated with warmth and restriction of knee movement. The overlying skin appears stretched but intact, with no redness or ulceration. There is no palpable lymphadenopathy, and distal pulses are well felt.

Laboratory studies show the following results:

TestResultReference RangeInterpretation
Hemoglobin10.5 g/dL12–16 g/dLMild anemia
ESR40 mm/hr<20 mm/hrElevated
CRPNormal<10 mg/LNormal
Alkaline Phosphatase (ALP)700 U/L<150 U/LMarkedly elevated
Lactate Dehydrogenase (LDH)550 U/L<250 U/LElevated

A plain X-ray of the distal femur shows a destructive lesion in the metaphyseal region with mixed lytic and sclerotic changes. There is periosteal elevation forming a Codman’s triangle, and a characteristic “sunburst” appearance of periosteal reaction. Cortical breach with extension into adjacent soft tissue is also seen. MRI confirms a large heterogeneous metaphyseal mass extending into surrounding soft tissue, but without encasement of the neurovascular bundle. A staging CT of the chest reveals small pulmonary nodules suggestive of metastases.

A core needle biopsy demonstrates malignant spindle-shaped cells producing osteoid, confirming the diagnosis of osteogenic sarcoma (osteosarcoma) of the distal femur with pulmonary metastases

Q5. What risk factors are associated with osteosarcoma?

Paget’s disease

Radiation

Bone infarction

Li-fraumeni syndrome

Retinoblastoma

Q6. Regarding osteogenic sarcoma, what investigations are useful to make a diagnosis and what is the clinical utility or the expected findings in each investigation?

X-ray of the affected area: best initial step. Also used for staging

“Sunburst” pattern (looks like cotton balls due to periosteal reaction)

Mass often extends beyond the periosteal margins

Codman triangle (newborn formation in response to periosteal lifting)

MRI: for staging. Delineates the medullary and extra-osseous extension of the tumor

CT-scan of chest: rule out lung metastases

Bone scan: evaluate for bone metastases

Biopsy: definitive histological diagnosis

Anaplastic or spindle-shaped cells with nuclear pleomorphism

Islands of osteoid (bone)

Alkaline phosphatase: elevated

Lactate dehydrogenase: elevated

Erythrocyte sedimentation rate: elevated

Q7. The characteristic periosteal reaction in osteosarcoma is a “sunburst” pattern or “Codman’s triangle”. What other periosteal reactions can occur with bone tumours?

Periosteal ReactionAppearanceSuggestive of
Solid/ContinuousSingle dense layerBenign, slow-growing (healing fracture, osteoid osteoma)
Lamellated (Onion-skin)Multiple concentric layersEwing’s sarcoma, osteomyelitis, lymphoma
Spiculated (Hair-on-end / Sunburst)Radiating spiculesOsteosarcoma, aggressive tumors
Codman’s TriangleTriangular elevation at tumor marginAggressive tumors (osteosarcoma, Ewing’s, metastases)
Periosteal reactions
Q8. The MSTS (Enneking) tumour staging system is a widely used framework for staging musculoskeletal tumours (bone and soft tissue sarcomas). What does it entail and how does this relate to treatment?

Enneking staging is based on 3 key factors:

Tumor grade (G): low-grade vs high-grade

Site or local spread (T): intra-compartmental vs extra-compartmental

Metastasis (M): no mets vs distant mets

MSTS (Enneking) staging

StageGradeSiteMetastasis
IALow gradeT1 – intracompartmentalM0
IBLow gradeT2 – extracompartmentalM0
IIAHigh gradeT1 – intracompartmentalM0
IIBHigh gradeT2 – extracompartmentalM0
IIIMetastaticT1 or T2 intracompartmental or extracompartmentalM1

Summary of staging and treatment

StageDescriptionTreatment
Stage I (low-grade)Grows slowly, rarely metastasizesWide local excision (with preservation of limb)
Stage II (high-grade)Grows rapidly with a higher risk of recurrence and metastasisWide local excision or radical excision. Limb salvage if clear margins are achievable vs amputation if limb cannot be salvaged. Adjuvant chemotherpay +/- radiotherapy
Stage III (metastatic disease)Poor prognosis.Multimodal treatment: systemic chemotherapy, surgical resection of primary tumor, possible resection of lung metastases, palliative care

A compartment is an anatomical space bounded by natural barriers, e.g., bone cortex or fascial envelope. This usually limits the spread of a tumour. For instance, the thigh has an anterior compartment, medial compartment, and posterior compartment based on fascial planes. In addition, each bone is considered a single compartment. For example, if a tumour is confined to the femur without soft-tissue extension, it is still intracompartmental.

Radiotherapy has a limited role in osteosarcoma since it is relatively radioresistant

Enneking Staging
Q9. What are the principles of surgery for bone tumours?

Type of ExcisionMargin Relative to TumorTypical Use
Intralesional excisionInside tumor (incomplete)Benign tumors, palliative care
Marginal excisionAt the tumor edge / pseudocapsuleSome benign aggressive tumors
Wide local excisionThrough normal tissue outside the reactive zone (with clear margins, within the same compartment)Limb-salvage for intra-compartmental tumours or low-grade malignant tumours
Radical excisionThe entire compartment was removedFor high-grade tumors, recurrence, or when a wide excision is not possible

Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Leave a Reply

A moment of your time
Step 1 of 2

You are the reason this exists. Got 60 seconds? Help us improve Hyperexcision for every medical student who uses it.

The Hyperexcision Team